Enabling 4D Proteomics and Epiproteomics

Executive Vice President, Life Sciences Spectrometry

Sep 8, 2021PA816

Data Analytical Development PA TV (video)

Bruker Daltonics Managing Director and Executive Vice President Dr. Rohan Thakur joins us to discuss how the company's innovative analytics tools are enabling 4D proteomics, epiproteomics, and beyond.

How Much of Your Last Year’s Research Budget Felt Wasted? The Hidden Cost of Experimental Inconsistencies

Sophie Lutter, Ph.D.; Andrew Chalmers, Ph.D.

Lab Thread

PAO-06-26-CL-05Jun 29, 2026

Gender Bias AI

Testing and Correcting Gender Bias in Healthcare AI

David Alvaro, Ph.D.

Pharma's Almanac

PAO-06-26-PA-21Jun 24, 2026

Data Integrity

Data Integrity: Drivers, Challenges, and Key Program Elements

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-06-26-PA-20Jun 23, 2026

LNP Strategy

Building Better RNA Medicines Through Smarter LNP Formulation Strategy

Aula Al Muslim, Ph.D.

Recipharm Advanced Bio

PAO-06-26-CL-03Jun 22, 2026

CRO Partnerships

Building Resilient Development Models: How Mid-Size Pharma Can Scale Without Losing Control

Brian Healey

IQVIA

PAO-06-26-CL-02Jun 17, 2026

Clinical Evidence

Rethinking Clinical Evidence Requirements in Rare Diseases

David Alvaro, Ph.D.

Pharma's Almanac

PAO-06-26-PA-09Jun 16, 2026

Digital Sampling

Enhancing Quality and Environmental Monitoring Efficiency Through Paperless Sampling

Jiwoon Kim; Neulbit Kim; Hyeonjung Park

Samsung Biologics

PAO-06-26-CL-01Jun 10, 2026

AI in Manufacturing

Validating and Governing AI in GMP Manufacturing

Pharma's Almanac

PAO-06-26-PA-03Jun 4, 2026

AI Data Integrity

Data Integrity in the Age of AI-Assisted Manufacturing

Pharma's Almanac

PAO-06-26-PA-02Jun 3, 2026

Oligo Analytics

Impurities, Sequence Fidelity, and Structural Variants in Nucleic Acid Therapeutics

David Alvaro, Ph.D.

Pharma's Almanac

PAO-05-26-PA-23May 26, 2026

Pathfinder

In Vitro vs. In Vivo Potency Assays: Which Approach Is Best for Biopharmaceutical Product Characterization?

Pharma's Almanac

PAO-26-PF-07May 15, 2026

PAT

Real-Time Insight in Biologic Manufacturing: Why PAT Matters for Commercial Scale-Up

David Alvaro, Ph.D.

Pharma's Almanac

PAO-04-26-PA-11Apr 16, 2026

Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us Nice Insight That's Nice

Reach Our Team

My Account

Subscribe for the newsletter

Subscribe for the Newsletter

Mobile Navigation

Enabling 4D Proteomics and Epiproteomics

Related Content

Preclinical R&D

How Much of Your Last Year’s Research Budget Felt Wasted? The Hidden Cost of Experimental Inconsistencies

Sophie Lutter, Ph.D.; Andrew Chalmers, Ph.D.

Lab Thread

Gender Bias AI

Testing and Correcting Gender Bias in Healthcare AI

David Alvaro, Ph.D.

Pharma's Almanac

Data Integrity

Data Integrity: Drivers, Challenges, and Key Program Elements

Cynthia A. Challener, Ph.D.

Pharma's Almanac

LNP Strategy

Building Better RNA Medicines Through Smarter LNP Formulation Strategy

Aula Al Muslim, Ph.D.

Recipharm Advanced Bio

CRO Partnerships

Building Resilient Development Models: How Mid-Size Pharma Can Scale Without Losing Control

Brian Healey

IQVIA

Clinical Evidence

Rethinking Clinical Evidence Requirements in Rare Diseases

David Alvaro, Ph.D.

Pharma's Almanac

Digital Sampling

Enhancing Quality and Environmental Monitoring Efficiency Through Paperless Sampling

Jiwoon Kim; Neulbit Kim; Hyeonjung Park

Samsung Biologics

AI in Manufacturing

Validating and Governing AI in GMP Manufacturing

Pharma's Almanac

AI Data Integrity

Data Integrity in the Age of AI-Assisted Manufacturing

Pharma's Almanac

Oligo Analytics

Impurities, Sequence Fidelity, and Structural Variants in Nucleic Acid Therapeutics

David Alvaro, Ph.D.

Pharma's Almanac

Pathfinder

In Vitro vs. In Vivo Potency Assays: Which Approach Is Best for Biopharmaceutical Product Characterization?

Pharma's Almanac

PAT

Real-Time Insight in Biologic Manufacturing: Why PAT Matters for Commercial Scale-Up

David Alvaro, Ph.D.

Pharma's Almanac

Related Content

Preclinical R&D

How Much of Your Last Year’s Research Budget Felt Wasted? The Hidden Cost of Experimental Inconsistencies

Sophie Lutter, Ph.D.; Andrew Chalmers, Ph.D.

Lab Thread

Gender Bias AI

Testing and Correcting Gender Bias in Healthcare AI

David Alvaro, Ph.D.

Pharma's Almanac

Data Integrity

Data Integrity: Drivers, Challenges, and Key Program Elements

Cynthia A. Challener, Ph.D.

Pharma's Almanac

LNP Strategy

Building Better RNA Medicines Through Smarter LNP Formulation Strategy

Aula Al Muslim, Ph.D.

Recipharm Advanced Bio

CRO Partnerships

Building Resilient Development Models: How Mid-Size Pharma Can Scale Without Losing Control

Brian Healey

IQVIA

Clinical Evidence

Rethinking Clinical Evidence Requirements in Rare Diseases

David Alvaro, Ph.D.

Pharma's Almanac

Digital Sampling

Enhancing Quality and Environmental Monitoring Efficiency Through Paperless Sampling

Jiwoon Kim; Neulbit Kim; Hyeonjung Park

Samsung Biologics

AI in Manufacturing

Validating and Governing AI in GMP Manufacturing